Characterization and in vitro sustained release of silibinin from ph responsive carbon nanotube-based drug delivery system

Journal of Nanomaterials

Volumn 2014, Issue , 2014, Pages

  Tan, Julia M ^a   Karthivashan, Govindarajan ^a   Arulselvan, Palanisamy ^a   Fakurazi, Sharida ^a   Hussein, Mohd Zobir ^a  

^a UNIVERSITY PUTRA MALAYSIA   (Malaysia)

Author keywords

[No Author keywords available]

Indexed keywords

CELL CULTURE; DRUG DELIVERY; FLAVONOIDS; MULTIWALLED CARBON NANOTUBES (MWCN); NANOSTRUCTURED MATERIALS; RAMAN SPECTROSCOPY; SCANNING ELECTRON MICROSCOPY; TRANSMISSION ELECTRON MICROSCOPY;

CARBOXYLATED MULTI-WALLED CARBON NANOTUBES; DRUG DELIVERY SYSTEM; FOURIER TRANSFORM INFRARED; HUMAN CANCER CELLS; KINETIC BEHAVIOUR; PSEUDO-SECOND-ORDER KINETIC MODELS; SUSTAINED RELEASE; ULTRAVIOLET-VISIBLE SPECTROPHOTOMETRY;

THERMOGRAVIMETRIC ANALYSIS;

EID: 84904126868     PISSN: 16874110     EISSN: 16874129     Source Type: Journal    
DOI: 10.1155/2014/439873     Document Type: Article

References (47)

1. Buzea C., Blandino I. I. P., Robbie K., Nanomaterials and nanoparticles: sources and toxicity. Biointerphases 2007 2 4 MR17 MR172
2. Hughes G. A., Nanostructure-mediated drug delivery. Nanomedicine: Nanotechnology, Biology, and Medicine 2005 1 1 22 30 2-s2.0-26244441643 10.1016/j.nano.2004.11.009 (Pubitemid 43963612)
3. Dorniani D., Kura A. U., Hussein-Al-Ali S. H., Hussein M. Z., Fakurazi S., Shaari A. H., Ahmad Z., In vitro sustained release study of gallic acid coated with magnetite-PEG and magnetite-PVA for drug delivery system. The Scientific World Journal 2014 2014 11 416354 10.1155/2014/416354
4. Barahuie F., Hussein M. Z., Hussein-Al-Ali S. H., Arulselvan P., Fakurazi S., Zainal Z., Preparation and controlled-release studies of a protocatechuic acid-magnesium/aluminumlayered double hydroxide nanocomposite. International Journal of Nanomedicine 2013 8 1975 1987 2-s2.0-84878083634 10.2147/IJN.S42718
5. Luo X., Matranga C., Tan S., Alba N., Cui X. T., Carbon nanotube nanoreservior for controlled release of anti-inflammatory dexamethasone. Biomaterials 2011 32 26 6316 6323 2-s2.0-79959886823 10.1016/j.biomaterials. 2011.05.020
6. Dolatabadi J. E. N., Omidi Y., Losic D., Carbon nanotubes as an advanced drug and gene delivery nanosystem. Current Nanoscience 2011 7 3 297 314 2-s2.0-79956286428 10.2174/157341311795542444
7. Iijima S., Carbon nanotubes: past, present, and future. Physica B: Condensed Matter 2002 323 1-4 1 5 2-s2.0-0036776713 10.1016/S0921-4526(02)00869- 4 (Pubitemid 35018984)
8. Peretz S., Regev O., Carbon nanotubes as nanocarriers in medicine. Current Opinion in Colloid and Interface Science 2012 17 6 360 368 2-s2.0-84870686056 10.1016/j.cocis.2012.09.001
9. Lu F., Gu L., Meziani M. J., Wang K., Luo P. G., Veca L. M., Cao L., Sun Y. P., Advances in bioapplications of carbon nanotubes. Advanced Materials 2009 21 2 139 152 2-s2.0-58649105112 10.1002/adma.200801491
10. Kostarelos K., Lacerda L., Pastorin G., Wu W., Wieckowski S., Luangsivilay J., Godefroy S., Pantarotto D., Briand J. P., Muller S., Prato M., Bianco A., Cellular uptake of functionalized carbon nanotubes is independent of functional group and cell type. Nature Nanotechnology 2007 2 2 108 113 2-s2.0-33846929427 10.1038/nnano.2006.209 (Pubitemid 46230832)
11. Bhirde A. A., Patel V., Gavard J., Zhang G., Sousa A. A., Masedunskas A., Leapman R. D., Weigert R., Gutkind S., Rusling J. F., Targeted killing of cancer cells in vivo and in vitro with EGF-directed carbon nanotube-based drug delivery. ACS Nano 2009 3 2 307 316 2-s2.0-63449106550 10.1021/nn800551s
12. Liu Z., Chen K., Davis C., Sherlock S., Cao Q., Chen X., Dai H., Drug delivery with carbon nanotubes for in vivo cancer treatment. Cancer Research 2008 68 16 6652 6660 2-s2.0-53049104252 10.1158/0008-5472.CAN-08-1468
13. Wong B. S., Yoong S. L., Jagusiak A., Panczyk T., Ho H. K., Ang W. H., Pastorin G., Carbon nanotubes for delivery of small molecule drugs. Advanced Drug Delivery Reviews 2013 65 15 1964 2015 10.1016/j.addr.2013.08.005
14. McDevitt M. R., Chattopadhyay D., Kappel B. J., Jaggi J. S., Schiffman S. R., Antczak C., Njardarson J. T., Brentjens R., Scheinberg D. A., Tumor targeting with antibody-functionalized, radiolabeled carbon nanotubes. Journal of Nuclear Medicine 2007 48 7 1180 1189 2-s2.0-34447329851 10.2967/jnumed.106. 039131 (Pubitemid 47052659)
15. Podesta J. E., Al-Jamal K. T., Herrero M. A., Tian B., Ali-Boucetta H., Hegde V., Bianco A., Prato M., Kostarelos K., Antitumor activity and prolonged survival by carbon-nanotube-mediated therapeutic sirna silencing in a human lung xenograft model. Small 2009 5 10 1176 1185 2-s2.0-67649890883 10.1002/smll.200801572
16. Pantarotto D., Partidos C. D., Hoebeke J., Brown F., Kramer E., Briand J.-P., Muller S., Prato M., Bianco A., Immunization with peptide-functionalized carbon nanotubes enhances virus-specific neutralizing antibody responses. Chemistry and Biology 2003 10 10 961 966 2-s2.0-0142229613 10.1016/j.chembiol. 2003.09.011 (Pubitemid 37316913)
17. Yang J., Liu Y. M., Liu Y. Z., Advances in the pharmaceutical research on the silymarin. Natural Product Research and Development 2004 16 2 185 187 (Pubitemid 38977754)
18. Kvasnička F., Bíba B., Ševčík R., Voldřich M., Krátká J., Analysis of the active components of silymarin. Journal of Chromatography A 2003 990 1-2 239 245 10.1016/S0021-9673(02)01971-4 (Pubitemid 36293880)
19. Lin C. M., Chen Y. H., Ma H. P., Wang B. W., Chiu J. H., Chua S. K., Ong J. R., Shyu K. G., Silibinin inhibits the invasion of IL-6-stimulated colon cancer cells via selective JNK/AP-1/MMP-2 modulation in vitro. Journal of Agricultural and Food Chemistry 2012 60 51 12451 12457 2-s2.0-84871546051 10.1021/jf300964f
20. Verschoyle R. D., Greaves P., Patel K., Marsden D. A., Brown K., Steward W. P., Gescher A. J., Evaluation of the cancer chemopreventive efficacy of silibinin in genetic mouse models of prostate and intestinal carcinogenesis: relationship with silibinin levels. European Journal of Cancer 2008 44 6 898 906 2-s2.0-41949087545 10.1016/j.ejca.2008.02.020
21. Cho H. J., Suh D. S., Moon S. H., Song Y. J., Yoon M. S., Park D. Y., Choi K. U., Kim Y. K., Kim K. H., Silibinin inhibits tumor growth through downregulation of extracellular signal-regulated kinase and Akt in vitro and in vivo in human ovarian cancer cells. Journal of Agricultural and Food Chemistry 2013 61 17 4089 4096 2-s2.0-84877015129 10.1021/jf400192v
22. Sun N. Y., Wei X. L., Wu B. J., Chen J., Lu Y., Wu W., Enhanced dissolution of silymarin/polyvinylpyrrolidone solid dispersion pellets prepared by a one-step fluid-bed coating technique. Powder Technology 2008 182 1 72 80 2-s2.0-38649102798 10.1016/j.powtec.2007.05.029 (Pubitemid 351173199)
23. El-Samaligy M. S., Afifi N. N., Mahmoud E. A., Increasing bioavailability of silymarin using a buccal liposomal delivery system: preparation and experimental design investigation. International Journal of Pharmaceutics 2006 308 1-2 140 148 2-s2.0-30744437915 10.1016/j.ijpharm.2005.11.006 (Pubitemid 43097245)
24. Zhang J. Q., Liu J., Li X. L., Jasti B. R., Preparation and characterization of solid lipid nanoparticles containing silibinin. Drug Delivery 2007 14 6 381 387 2-s2.0-34547957453 10.1080/10717540701203034 (Pubitemid 47265822)
25. Yu J. N., Zhu Y., Wang L., Peng M., Tong S. S., Cao X., Qiu H., Xu X. M., Enhancement of oral bioavailability of the poorly water-soluble drug silybin by sodium cholate/phospholipid-mixed micelles. Acta Pharmacologica Sinica 2010 31 6 759 764 2-s2.0-77953283333 10.1038/aps.2010.55
26. Wei Y., Ye X., Shang X., Peng X., Bao Q., Liu M., Guo M., Li F., Enhanced oral bioavailability of silybin by a supersaturatable self-emulsifying drug delivery system (S-SEDDS). Colloids and Surfaces A: Physicochemical and Engineering Aspects 2012 396 22 28 2-s2.0-84857356952 10.1016/j.colsurfa.2011. 12.025
27. Wang Y., Zhang D., Liu Z., Liu G., Duan C., Jia L., Feng F., Zhang X., Shi Y., Zhang Q., In vitro and in vivo evaluation of silybin nanosuspensions for oral and intravenous delivery. Nanotechnology 2010 21 15 2-s2.0-77949885658 10.1088/0957-4484/21/15/155104 155104
28. Cao X., Deng W., Fu M., Zhu Y., Liu H., Wang L., Zeng J., Wei Y., Xu X., Yu J., Seventy-two-hour release formulation of the poorly soluble drug silybin based on porous silica nanoparticles: in vitro release kinetics and in vitro / in vivo correlations in beagle dogs. European Journal of Pharmaceutical Sciences 2013 48 1-2 64 71 2-s2.0-84869865253 10.1016/j.ejps.2012.10.012
29. El-Sherbiny I. M., Abdel-Mogib M., Dawidar A. A. M., Elsayed A., Smyth H. D. C., Biodegradable pH-responsive alginate-poly (lactic-co-glycolic acid) nano/micro hydrogel matrices for oral delivery of silymarin. Carbohydrate Polymers 2011 83 3 1345 1354 2-s2.0-78650272586 10.1016/j.carbpol.2010.09.055
30. Chen Z., Pierre D., He H., Tan S., Chuong P.-H., Hong H., Huang J., Adsorption behavior of epirubicin hydrochloride on carboxylated carbon nanotubes. International Journal of Pharmaceutics 2011 405 1-2 153 161 2-s2.0-79151476919 10.1016/j.ijpharm.2010.11.034
31. Liu L., Qin Y., Guo Z. X., Zhu D., Reduction of solubilized multi-walled carbon nanotubes. Carbon 2003 41 2 331 335 2-s2.0-0037212143 10.1016/S0008-6223(02)00286-5 (Pubitemid 35460219)
32. Ma Y., Li W. Z., Gu J. H., Preparation and evaluation of the solid dispersions of poorly soluble silybin. Journal of Chinese Pharmaceutical Sciences 2011 20 6 604 608 2-s2.0-84860899767 10.5246/jcps.2011.06.078
33. Sethia S., Squillante E., Solid dispersion of carbamazepine in PVP K30 by conventional solvent evaporation and supercritical methods. International Journal of Pharmaceutics 2004 272 1-2 1 10 2-s2.0-1442348833 10.1016/j.ijpharm.2003.11.025 (Pubitemid 38293005)
34. Song W., Zheng Z., Tang W., Wang X., A facile approach to covalently functionalized carbon nanotubes with biocompatible polymer. Polymer 2007 48 13 3658 3663 2-s2.0-34249828985 10.1016/j.polymer.2007.04.071 (Pubitemid 46856555)
35. Adeli M., Hakimpoor F., Ashiri M., Kabiri R., Bavadi M., Anticancer drug delivery systems based on noncovalent interactions between carbon nanotubes and linear-dendritic copolymers. Soft Matter 2011 7 8 4062 4070 2-s2.0-79953762778 10.1039/c0sm01550d
36. Datsyuk V., Kalyva M., Papagelis K., Parthenios J., Tasis D., Siokou A., Kallitsis I., Galiotis C., Chemical oxidation of multiwalled carbon nanotubes. Carbon 2008 46 6 833 840 2-s2.0-43049098469 10.1016/j.carbon.2008.02.012
37. Tang M., Dou H., Sun K., One-step synthesis of dextran-based stable nanoparticles assisted by self-assembly. Polymer 2006 47 2 728 734 2-s2.0-30144432589 10.1016/j.polymer.2005.11.091 (Pubitemid 43053275)
38. Ntim S. A., Sae-Khow O., Witzmann F. A., Mitra S., Effects of polymer wrapping and covalent functionalization on the stability of MWCNT in aqueous dispersions. Journal of Colloid and Interface Science 2011 355 2 383 388 2-s2.0-79551473550 10.1016/j.jcis.2010.12.052
39. 2-PEG hybrid materials. Journal of Non-Crystalline Solids 2006 352 3 273 280 2-s2.0-31844445432 10.1016/j.jnoncrysol.2005.11.033 (Pubitemid 43180106)
40. Hou P., Liu C., Tong Y., Xu S., Liu M., Cheng H., Purification of single-walled carbon nanotubes synthesized by the hydrogen arc-discharge method. Journal of Materials Research 2001 16 9 2526 2529 2-s2.0-0001604099 (Pubitemid 33694087)
41. Li Y., Wang T., Wang J., Jiang T., Cheng G., Wang S., Functional and unmodified MWNTs for delivery of the water-insoluble drug Carvedilol-a drug-loading mechanism. Applied Surface Science 2011 257 13 5663 5670 2-s2.0-79952536754 10.1016/j.apsusc.2011.01.071
42. Shieh Y. T., Liu G. L., Wu H. H., Lee C. C., Effects of polarity and pH on the solubility of acid-treated carbon nanotubes in different media. Carbon 2007 45 9 1880 1890 2-s2.0-34447574633 10.1016/j.carbon.2007.04.028 (Pubitemid 47069234)
43. Hussein-Al-Ali S. H., Al-Qubaisi M., Hussein M. Z., Ismail M., Zainal Z., Hakim M. N., In vitro inhibition of histamine release behavior of cetirizine intercalated into Zn/Al- and Mg/Al-layered double hydroxides. International Journal of Molecular Sciences 2012 13 5 5899 5916 2-s2.0-84861553669 10.3390/ijms13055899
44. Dong L., Yan L., Hou W. G., Liu S. J., Synthesis and release behavior of composites of camptothecin and layered double hydroxide. Journal of Solid State Chemistry 2010 183 8 1811 1816 2-s2.0-77955466615 10.1016/j.jssc.2010.05.035
45. Ho Y. S., Ofomaja A. E., Pseudo-second-order model for lead ion sorption from aqueous solutions onto palm kernel fiber. Journal of Hazardous Materials 2006 129 1-3 137 142 2-s2.0-33644545070 10.1016/j.jhazmat.2005.08.020
46. Singh R. P., Agarwal R., Prostate cancer prevention by silibinin. Current Cancer Drug Targets 2004 4 1 1 11 2-s2.0-1542409976 (Pubitemid 38332560)
47. Karim B. O., Rhee K. J., Liu G., Zheng D., Huso D. L., Chemoprevention utility of silibinin and Cdk4 pathway inhibition in A p c-/ + mice. BMC Cancer 2013 13, article 157 2-s2.0-84875344694 10.1186/1471-2407-13-157